CLINICAL_TRIALS
trial_result
· 2026-06-29
Clinical Trial Update: Avelumab Program Rollover Study [Phase 3]
Summary
A Phase 3 rollover study of avelumab for solid tumors is active not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Solid Tumors | Phase 3 | Status: ACTIVE_NOT_RECRUITING